BIPS 2nd Global Biomedical Innovation Pioneer China Summit 2022

BIPS 2nd Global Biopharmaceutical Innovation Pioneer China Summit 2022 and Conference Introduction of Biopharmaceutical R&D Innovation Pioneer Forum and Biopharmaceutical Process Innovation Pioneer Forum "The 2nd Global Biomedical Innovation Pioneer China Summit 2022" (2nd Global Biopharma Innovation Pioneer China Summit 2022) ·It will be held in Shanghai on May 26-27, 2022
.

·The summit includes two parallel forums, namely, the Pioneer Forum of Biomedical R&D Innovation and the Pioneer Forum of Biopharmaceutical Process Innovation
.

·Two parallel forums focus on "Innovative Drug R&D" and "Biopharmaceutical Technology" respectively.
At that time, R&D team members from multinational and local pharmaceutical companies, biotechnology companies, contract R&D and manufacturing service companies and upstream supporting equipment companies, pharmaceutical technology Developers, production managers and business cooperation leaders will gather together to discuss technological innovation and global cooperation in China's biopharmaceutical industry
.

·The main hot topics covered by this summit include China Biopharma 4.
0 and process innovation; R&D innovation and industrialized manufacturing of cell and gene therapy; AI accelerates innovative drug R&D; companion diagnostics enables drug R&D; antibody drugs and small molecules Innovative drug research and development of targeted drugs and upstream and downstream process development and industrialization of antibody drugs; future prospects of nucleic acid drugs ASO, siRNA and mRNA,
etc.

·This summit will be presented to you offline and online simultaneously, in various forms such as keynote speeches, roundtable discussions, guest interviews, and one-on-one meetings.
A platform for the development of quality contacts
.

 　　6: The application of intelligently designed antibody technology in tumor immune drug development Roundtable Forum: AI Drug Development: Technology, Cases, Market Status and Future Prospects Process innovation China's biopharmaceutical innovation trends: 2022 and future new drug CMC's key risk analysis and response QbD framework of innovative drug formulation R&D and technology transfer integration Development and application of ultra-efficient continuous bioprocess pharmaceutical companies GMP compliance self-inspection and Internal Audit Management Modular Biomanufacturing Solutions Helping Biopharmaceutical Industry Upgrade Roundtable Discussion: How will China's biopharmaceutical technology and industry landscape evolve in the next five years? Industrialization of Cell and Gene Therapy: Cost Reduction and Efficiency From Production to Clinic: How to Accelerate the Development of Cell Therapy CAR-T Cell Therapy Products CMC Key Cell Therapy Clinic, Production and Quality Control Cell and Gene Therapy Drugs GMP Factory Design Perfusion Culture in Applications in Cell Therapy Upstream Processes Trends and Challenges in Gene Therapy AAV Vector Process Development and Mass Production Key Considerations for Process Improvement and Process Changes Purification of Bispecific Antibodies and Cell Line Construction of ADC Drugs CMC Development Strategy and Experience Sharing Virus clearance strategy Construction of high-expressing CHO cell line and development strategy and case of new generation serum-free medium Roundtable Forum: Challenges and strategies for large-scale antibody preparation Challenges and Solutions Development of LNP Delivery System for Next-Generation Nucleic Acid Drugs mRNA Vaccine Development and Production RNA Targeted Drug Design Strategy and Production Process Optimization Small Nucleic Acid Synthesis and CMC Process Gene Therapy Large-scale Plasmid Production Process Breakthrough Roundtable Forum: Nucleic Acid Drugs Sponsor Contacts for Finishing, Delivery and Process Development (see download below) Cover Media Group